Bicyclic fibrinogen antagonists

Details Bicyclic fibrinogen antagonists Bicyclic fibrinogen antagonists

1999-05-14

2000-10-03

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

51421109, 5142111, 540484, 540544, 540545, 540546, 540552, 424 9463, A61K 3155, A61K 3748, C07D22708

Patent

active

061273597

ABSTRACT:
Compounds of the formula: ##STR1## wherein A.sup.1 to A.sup.5 form a seven-membered ring containing one optionally substituted nitrogen atom and one heteroatom selected from oxygen and nitrogen;

REFERENCES:
patent: 4297346 (1981-10-01), Rips et al.
patent: 4322346 (1982-03-01), Korosi et al.
patent: 4327026 (1982-04-01), Branca et al.
patent: 4361511 (1982-11-01), Branca et al.
patent: 4377522 (1983-03-01), Branca et al.
patent: 4410520 (1983-10-01), Watthey et al.
patent: 4568543 (1986-02-01), Borrelli et al.
patent: 4604389 (1986-08-01), Reiffen et al.
patent: 4737495 (1988-04-01), Bomhard et al.
patent: 4808713 (1989-02-01), Attwood et al.
patent: 4820834 (1989-04-01), Evans et al.
patent: 5008263 (1991-04-01), Cooper et al.
patent: 5017571 (1991-05-01), Hansen et al.
patent: 5059688 (1991-10-01), Effland et al.
patent: 5096900 (1992-03-01), George et al.
patent: 5149699 (1992-09-01), Ellingboe et al.
patent: 5241065 (1993-08-01), Berger et al.
patent: 5250679 (1993-10-01), Blackburn et al.
patent: 5403836 (1995-04-01), Blackburn et al.
patent: 5438118 (1995-08-01), Callahan et al.
patent: 5470849 (1995-11-01), Callahan et al.
patent: 5565449 (1996-10-01), Blackburn et al.
patent: 5663166 (1997-09-01), Blackburn et al.
patent: 5674863 (1997-10-01), Blackburn et al.
patent: 5674865 (1997-10-01), Blackburn et al.
patent: 5693636 (1997-12-01), Bondinell et al.
patent: 5939412 (1999-08-01), Bondinell et al.
Sternbach, L.H., J. Med. Chem., 22, 2 (1979).
Friedinger, R.M., Cholecystokinin and Gastrin Antagonists, Med. Res. Rev., 9, 271 (1989).
Mori et al., New Synthesis of Diazepinone Skeleton Using Palladium Catalyzed Carbonylation, Heterocycles, 16 (1981).
Muller et al., Synthese von 1, 2-annelierten 1,4-Benzodiazepinen und 4, 1-Benzoxazepinen, Helv. Chim. Acta, 65, 2118 (1982).
Heindel et al., Synthesis, Transformation and General Pharmacologic Activity in 1,4-Benzodiazepine-3,5-Diones, J. Med. Chem., 14, 1233 (1971).
Pauwells et al., Potent and Selective Inhibition of HIV-1 Replication in vitro by a Novel Series of TIBO Derivatives, Nature, 343,470 (1990).
Nichols et al., J. Pharm. Exp. Ther., 270, 614 (1994).
Coller, Coronary Artery Disease, 3, 1016 (1992).
Topol et al. Thrombosis and Haemostasis, 70, 94 (1993).
Nichols et al., TIPS, 13, 413 (Nov. 1991).
Tighneanu et al., Double Cyclisation of Phenyglycine-o-carboxylic Acids-I, Tetrahedron, 36, 1385 (1980).
Callahan et al., Peptide Chemistry 1992: Proceedings of the 2nd Japanese Symposium on Peptides Chemistry, p. 495 (1993).
Ku et al., J. Am. Chem. Soc., 115, 8861 (1993).
Tidwell et al., Thrombosis Research, vol. 19, pp. 339-349 (1980).
Ku et al., J. Med. Chem., 38(1), pp. 9-12 (1995).

Affiliated with

Also associated with

Rating

Bicyclic fibrinogen antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic fibrinogen antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic fibrinogen antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-195723